U.S. flag

An official website of the United States government

NM_000363.5(TNNI3):c.298C>T (p.Leu100Phe) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 6, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001193548.2

Allele description [Variation Report for NM_000363.5(TNNI3):c.298C>T (p.Leu100Phe)]

NM_000363.5(TNNI3):c.298C>T (p.Leu100Phe)

Gene:
TNNI3:troponin I3, cardiac type [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.42
Genomic location:
Preferred name:
NM_000363.5(TNNI3):c.298C>T (p.Leu100Phe)
HGVS:
  • NC_000019.10:g.55154815G>A
  • NG_007866.2:g.7918C>T
  • NM_000363.5:c.298C>TMANE SELECT
  • NP_000354.4:p.Leu100Phe
  • LRG_432t1:c.298C>T
  • LRG_432:g.7918C>T
  • NC_000019.9:g.55666183G>A
  • NM_000363.4:c.298C>T
Protein change:
L100F
Links:
dbSNP: rs773216333
NCBI 1000 Genomes Browser:
rs773216333
Molecular consequence:
  • NM_000363.5:c.298C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001362448Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 6, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.

Robyns T, Breckpot J, Nuyens D, Vandenberk B, Corveleyn A, Kuiperi C, Van Aelst L, Van Cleemput J, Willems R.

Eur J Med Genet. 2020 Mar;63(3):103754. doi: 10.1016/j.ejmg.2019.103754. Epub 2019 Sep 9.

PubMed [citation]
PMID:
31513939

Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.

Robyns T, Kuiperi C, Breckpot J, Devriendt K, Souche E, Van Cleemput J, Willems R, Nuyens D, Matthijs G, Corveleyn A.

Eur J Hum Genet. 2017 Dec;25(12):1313-1323. doi: 10.1038/s41431-017-0004-3. Epub 2017 Oct 10.

PubMed [citation]
PMID:
29255176
PMCID:
PMC5865127

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001362448.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: TNNI3 c.298C>T (p.Leu100Phe) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 249422 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.298C>T has been reported in the literature in two sisters diagnosed with Hypertrophic cardiomyopathy and mild hypertrophy, however authors classified the variant as VUS (examples: Robyns_2017, and Robyns_2020). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024